Related Experiment Videos
End-stage renal care in developing countries: the India experience
1Postgraduate Institute of Medical Education and Research, Chandigarh, India. vjha@iname.com
Renal Failure
|September 10, 2004
Summary
Renal replacement therapy is unaffordable in developing nations, leading to inadequate treatment and severe financial strain on families. Limited resources and high costs create significant barriers to essential kidney disease care.
Area of Science:
- Nephrology
- Public Health
- Health Economics
Background:
- Chronic renal failure presents a significant medical, social, and economic challenge globally.
- Developing nations lack data on chronic renal failure incidence and prevalence, often resulting in delayed diagnoses.
- A predominantly young end-stage renal disease (ESRD) population emerges due to delayed interventions.
Purpose of the Study:
- To investigate the challenges and financial burdens associated with renal replacement therapy (RRT) in developing countries.
- To highlight the disparities in healthcare access and resource allocation for kidney disease management.
- To examine the socioeconomic impact of RRT on patients and their families in resource-limited settings.
Main Methods:
- Analysis of existing literature and healthcare system structures in developing nations.
- Examination of RRT modalities including hemodialysis and transplantation.
- Assessment of financial accessibility, treatment compromises, and patient outcomes.
Main Results:
- RRT is a low-priority healthcare area with severe shortages of nephrologists and facilities.
- High costs of hemodialysis and peritoneal dialysis limit access, with private hospitals dominating RRT provision.
- Patients and families face immense financial burdens, leading to treatment compromises, graft loss, and unethical practices like kidney sales.
Conclusions:
- The financial burden of RRT in developing nations profoundly impacts patients' lives and families.
- Inadequate healthcare infrastructure and funding necessitate innovative solutions for sustainable kidney disease management.
- Urgent attention is required from healthcare planners to address the critical disparities in RRT access and affordability.